Opioid detox for West Palm Beach — fentanyl-era protocols, buprenorphine done right.

RECO Island runs a small-census, physician-led opioid detox 28 minutes south of West Palm Beach at the Delray Beach campus. Buprenorphine induction is COWS-guided and calibrated for fentanyl-exposed patients, including low-dose and Bernese-style micro-induction protocols where indicated. Detox and residential care operate under one medical director and one roof — no waitlist, no third-party handoff, and no restart of the intake process at the next level of care.

West Palm Beach sits 18 miles north of RECO Island’s Delray Beach campus — about 28 minutes down I-95 or Federal Highway outside rush hour. For residents of El Cid, Flamingo Park, Northwood Hills, SoSo, and downtown WPB, the Delray campus is the nearest small-census, physician-led medical detox that transitions directly into in-house residential treatment, with no waitlist and no third-party handoff. Opioid detox here is COWS-guided, buprenorphine-forward, and calibrated for the fentanyl era.

Opioid withdrawal in the fentanyl era

Fentanyl and its analogs have materially changed the presentation and management of opioid withdrawal in South Florida. The drug’s potency — roughly 50 to 100 times that of morphine — combined with a short elimination half-life and lipophilic tissue redistribution produces a withdrawal syndrome that emerges faster, hits harder, and behaves less predictably than withdrawal from heroin or prescription oxycodone. Autonomic hyperactivity, severe GI distress, and dysphoria often peak inside the first 24-48 hours rather than the classical 72-hour window.

Adulterants complicate the picture further. Xylazine — a veterinary alpha-2 agonist now present in a substantial share of the East Coast fentanyl supply — produces a sedative component that does not respond to naloxone and can extend the course with prolonged autonomic instability and characteristic skin ulcerations. Buprenorphine induction, historically initiated at 12-24 hours of moderate withdrawal, now often requires longer intervals or micro-induction protocols to avoid precipitated withdrawal in fentanyl-exposed patients. RECO Island’s opioid detox protocol reflects current addiction medicine practice — not the pre-fentanyl playbook that still lingers in outdated programs.

COWS-guided buprenorphine induction

The Clinical Opiate Withdrawal Scale (COWS) scores eleven symptom domains: resting pulse rate, sweating, restlessness, pupil size, bone and joint aches, rhinorrhea or lacrimation, GI upset, tremor, yawning, anxiety or irritability, and gooseflesh skin. Total scores map to withdrawal severity — 5-12 mild, 13-24 moderate, 25-36 moderately severe, above 36 severe. Nursing staff at RECO Island document COWS every two to four hours during the acute phase and use the trajectory, not a single snapshot, to time induction.

Induction begins when COWS crosses the moderate threshold, typically 11 or higher, with an initial dose of 2-4 mg sublingual buprenorphine and titration over the first day toward a clinically effective range of 8-16 mg daily. For fentanyl-exposed patients, low-dose or Bernese-style micro-induction protocols may be used — overlapping small buprenorphine doses with a tapering short-acting opioid to avoid a precipitated crash. Comfort medications supplement the induction itself: clonidine for autonomic symptoms, loperamide for diarrhea, ondansetron for nausea, hydroxyzine or a brief course of a muscle relaxant for cramping, and trazodone for sleep restoration.

Buprenorphine, methadone, or naltrexone — the MAT decision

Post-detox medication-assisted treatment for opioid use disorder has three options with strong evidence, and each has its indication. Buprenorphine — a partial mu agonist with a ceiling on respiratory depression — is office-based, tolerates missed doses reasonably well, and pairs cleanly with residential and outpatient care. Methadone, a full agonist, remains the standard for patients with the highest tolerance, extensive prior treatment failure, or a preference for the structured daily-dosing model of a federally licensed opioid treatment program. Extended-release naltrexone (Vivitrol) — an opioid antagonist delivered as a monthly intramuscular injection — is a strong option for the client who wants a non-opioid maintenance medication, but it requires a 7-10 day opioid-free window before the first dose to avoid precipitated withdrawal.

The MAT decision is made with the client during the detox stay, informed by prior response, urine toxicology, coexisting psychiatric diagnoses assessed with the PHQ-9 and GAD-7, and what community-level continuity of care looks like at discharge — including whether West Palm Beach prescribers accept the client’s insurance and whether transportation to daily dosing is realistic.

Naloxone education and the safety net

Overdose mortality risk is highest in the four weeks immediately following detox. Opioid tolerance has dropped, but the neurobiological and environmental drivers of return-to-use have not — and a dose that felt routine at admission is now potentially lethal. This is the interval where naloxone matters most.

Every RECO Island opioid detox client and, when the client consents, at least one family member receives naloxone education and a take-home prescription at discharge. Training covers how to recognize an overdose (unresponsiveness, pinpoint pupils, agonal breathing), how to administer intranasal naloxone, and how to manage the post-reversal window — including the possibility of a second dose as fentanyl outlasts the naloxone. Harm-reduction counseling and MAT continuation are the two interventions with the strongest mortality-reduction evidence in this population. Neither is optional programming at RECO Island; both are part of the medical standard of care.

The first 72 hours and the residential handoff

Admission from West Palm Beach typically begins with a phone-based clinical screen the same day, followed by transport or self-arrival at the Delray Beach campus. On arrival, a physician H&P, nursing assessment, urine toxicology and basic metabolic labs, and a psychiatric intake — including PHQ-9, GAD-7, and where indicated the ASRS or YBOCS — are completed within the first several hours. COWS scoring begins immediately and drives induction timing.

The first 24-48 hours focus on symptom control and buprenorphine induction; days two and three shift toward stabilization on the maintenance dose, restoration of sleep and nutrition, and introduction to the clinical team the client will work with in residential treatment. Because RECO Island operates detox and residential care under the same medical director and the same roof, there is no discharge-and-refer step, no waitlist for the next level of care, and no new intake process. The individualized treatment plan started in detox — CBT, DBT, motivational interviewing, and trauma-focused work where indicated — continues without a handoff.

Insurance and admissions from West Palm Beach

RECO Island is in-network with most major commercial carriers used across Palm Beach County — Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. A single call with the client’s insurance information and a brief clinical description produces a verification of benefits and a same-day admission decision in most cases. Admissions counselors coordinate with employers, family members, and referring providers when the client authorizes that contact in writing.

Transport from West Palm Beach — 18 miles and 28 minutes on I-95 or Federal Highway — is arranged when needed, including pickups from PBIA or from a hospital emergency department after medical clearance. Level of care is anchored to ASAM Criteria assessment across the six dimensions, not to schedule availability, so residents of Flamingo Park, El Cid, Northwood Hills, SoSo, and downtown WPB start at the appropriate acuity from day one.

Serving residents of: El Cid, Flamingo Park, Northwood Hills, SoSo, Downtown WPB.